40
Participants
Start Date
October 17, 2022
Primary Completion Date
May 10, 2024
Study Completion Date
November 16, 2024
eGFR reporting
"To test the proportion of patients successfully completing the protocol according to different eGFR reporting strategies, randomization in a 1:1 fashion at the patient level (n=50) will occur as follows:~1. only study-related eGFR values \>25% below baseline will be reported to patients and providers~2. all study-related eGFR will be provided to patients and providers"
Brigham and Women's, Boston
Martina McGrath, MD
OTHER